Clinical Trial Update: Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China [Phase 4]

View source ↗

Summary

This Phase 4 open-label study in China evaluated the antibody and cytokine response to the Hepatitis B vaccine in patients with chronic hepatitis C who were not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: Shandong Province Centers for Disease Control and Prevention | Conditions: Hepatitis B Vaccines | Phase 4 | Status: COMPLETED